Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: A phase II study

Gabriella Ferrandina, M. Ludovisi, R. De Vincenzo, V. Salutari, D. Lorusso, M. Colangelo, T. Prantera, M. R. Valerio, G. Scambia

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: A phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences